Zimmer Biomet today announced FDA clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System that offers a more customized experience for surgeons.
ROSA Knee with OptimiZe personalizes the surgeon's experience with customized intelligent surgical planning and new positioning, tracking and alignment features. The technology provides a simplified user interface.
Designed for use with the Persona Knee System, ROSA Knee with OptimiZe enables surgeons who use functional alignment to use customizable surgeon profiles that systematically provide surgical plans to automatically position the implant and balance the knee based on the patient's own anatomy and the surgeon's preferences. For surgeons who prefer kinematic alignment, the system offers the industry's only automated kinematic alignment feature to resurface the knee with the goal of restoring its pre-arthritic position and native joint lines.
ROSA Knee with OptimiZe integrates with ZBEdge Analytics to enable surgeons to make data-driven intra-operative decisions, objectively assess their performance and understand the potential impact of clinical decisions on patient recovery.
Zimmer Biomet will conduct a targeted release of ROSA Knee with OptimiZe later this year with commercial availability in the U.S. expected in the first quarter of 2026.
